Citadel Advisors’s Athenahealth, Inc. ATHN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-794,608
Closed -$105M 10308
2018
Q4
$105M Buy
794,608
+35,075
+5% +$4.49M 0.06% 307
2018
Q3
$101M Buy
759,533
+705,832
+1,314% +$106M 0.05% 410
2018
Q2
$8.55M Sell
53,701
-51,331
-49% -$7.61M ﹤0.01% 2117
2018
Q1
$15M Buy
105,032
+60,012
+133% +$8.2M 0.01% 1365
2017
Q4
$5.99M Sell
45,020
-165,971
-79% -$21.2M ﹤0.01% 2263
2017
Q3
$26.2M Buy
210,991
+133,186
+171% +$18.3M 0.02% 905
2017
Q2
$10.9M Sell
77,805
-90,030
-54% -$11.2M 0.01% 1385
2017
Q1
$18.9M Buy
+167,835
New +$19.6M 0.02% 996
2016
Q4
Sell
-13,983
Closed -$1.5M 8191
2016
Q3
$1.76M Sell
13,983
-29,882
-68% -$3.8M ﹤0.01% 3117
2016
Q2
$6.05M Sell
43,865
-64,234
-59% -$8.5M 0.01% 1662
2016
Q1
$15M Buy
108,099
+28,430
+36% +$3.9M 0.02% 919
2015
Q4
$12.8M Sell
79,669
-339,473
-81% -$52.4M 0.01% 1098
2015
Q3
$55.9M Buy
419,142
+239,111
+133% +$31.2M 0.05% 387
2015
Q2
$20.6M Buy
180,031
+159,921
+795% +$19.1M 0.02% 976
2015
Q1
$2.4M Buy
20,110
+15,457
+332% +$2.06M ﹤0.01% 2839
2014
Q4
$678K Sell
4,653
-11,572
-71% -$1.45M ﹤0.01% 4291
2014
Q3
$2.14M Buy
16,225
+6,565
+68% +$865K ﹤0.01% 2787
2014
Q2
$1.21M Buy
9,660
+4,823
+100% +$623K ﹤0.01% 3258
2014
Q1
$775K Sell
4,837
-185,364
-97% -$30.5M ﹤0.01% 3753
2013
Q4
$25.6M Buy
190,201
+189,588
+30,928% +$24.4M 0.03% 663
2013
Q3
$66K Sell
613
-272,722
-100% -$29.5M ﹤0.01% 5619
2013
Q2
$23.2M Buy
+273,335
New +$24.5M 0.04% 582

Citadel Advisors's ATHN Position: Q1 2019 in Review

Citadel Advisors sold out of Athenahealth, Inc. (ATHN) in Q1 2019, closing a stake of 794,608 shares — an estimated $105M sold.

Citadel Advisors first reported a position in ATHN in Q2 2013 and held it in 22 quarters. The position peaked at $105M in Q4 2018. 0 funds tracked by Wall St. Rank hold ATHN as of Q1 2019.

  • Citadel Advisors reported no remaining Athenahealth, Inc. position as of Q1 2019 after selling out during the quarter.
  • Citadel Advisors sold 794,608 Athenahealth, Inc. shares in Q1 2019, an estimated $105M.
  • Citadel Advisors first reported a position in Athenahealth, Inc. in Q2 2013 and held it in 22 quarters.
  • Citadel Advisors's Athenahealth, Inc. position peaked at $105M in Q4 2018.
  • 0 funds tracked by Wall St. Rank held Athenahealth, Inc. as of Q1 2019.

Based on Citadel Advisors's 13F filing for Q1 2019, filed 15 May 2019.